ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

252
Analysis
Health Care • India
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company that researches, develops, manufactures, and markets a wide array of pharmaceutical products and services. The company produces over 190 medications, 60 active pharmaceutical ingredients, diagnostic kits, critical care, and biotechnology products. It operates globally across multiple regions, offering generic drugs, active pharmaceutical ingredients (APIs), differentiated formulations, biosimilars, and proprietary products. The company was founded in 1984 and is headquartered in Hyderabad, Telangana, India.
more
•31 Dec 2016 20:34•Syndicated

Pakistan Market Outlook 2017

Pakistan market is expected to continue its uptrend in 2017 given tangible gains from China Pakistan Economic Corridor (CPEC) projects and rising...

Logo
572 Views
Share
•28 Jan 2023 06:38•Broker

Dr Reddy Lab Ltd - GRevlimid-Fuelled Growth in the US

gRevlimid sales ($125 Mn), led to the overall growth of the US business to $370 Mn (+47%, YoY). The rest of the US-based portfolio ($245 Mn),...

Logo
487 Views
Share
•27 Dec 2022 09:22•Broker

Pick of the Week - Dr Reddy’s Laboratories Ltd

Dr Reddy’s Laboratories Ltd (DRREDDY) is a global pharmaceutical company committed to providing access to affordable and innovative medicines.

Logo
767 Views
Share
•02 Nov 2022 08:28•Broker

Dr. Reddy’s Laboratories Ltd - New Launches to Add Growth and Profitability!

The growth was driven by the launch of gRevlimid in the US and sequential improvement in Russian sales, which was only partially offset by price...

Logo
185 Views
Share
•07 Jun 2022 07:36•Broker

Dr. Reddy's Laboratories - Management Meet Update

We hosted the management of Dr. Reddy’s Laboratories Ltd at our Annual Investor Conference to discuss the business outlook. The company expects to...

Logo
324 Views
Share
x